DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Ando H, Ishida T.
An RNAi therapeutic, DFP-10825, for intraperitoneal and intrapleural malignant cancers.
Adv Drug Deliv Rev 2020;
154–155: 27-36
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.